Atlas Trials

An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

Clinical trial NCT06951425 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06951425
Sponsor
Shanghai Tongji Hospital, Tongji University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2025-06-01
Primary completion
2028-11-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.